Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment - New 5-HT(1A) receptor ligands

Archiv der Pharmazie

Volumn 329, Issue 10, 1996, Pages 451-456

  Paluchowska, Maria H ^a   Dereń Wesołek, Anna ^a   Mokrosz, Jerzy L ^a   Charakchieva Minol, Sijka ^a   Chojnacka Wójcik, Ewa ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 adrenergic receptor ligands; 1 (2 methoxyphenyl)piperazines; 5 HT(1A) receptor antagonist; 5 HT(1A) receptor ligands; 5 HT(1A) receptor partial agonist

Indexed keywords

PIPERAZINE DERIVATIVE; RECEPTOR SUBTYPE; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; 4 (3 (BENZOTRIAZOL 1 YL)PROPYL) 1 (2 METHOXYPHENYL)PIPERAZINE; 4-(3-(BENZOTRIAZOL-1-YL)PROPYL)-1-(2-METHOXYPHENYL)PIPERAZINE; ISOQUINOLINE DERIVATIVE; LIGAND; NITROGEN; SEROTONIN 1 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; ANIMAL; CHEMISTRY; DRUG EFFECT; METABOLISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS; WISTAR RAT;

ANIMALS; ISOQUINOLINES; LIGANDS; MALE; NITROGEN; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 0030255033     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19963291006     Document Type: Article

References (18)

1. Part 30: J. L. Mokrosz, M. J. Mokrosz, B. Duszyńska, A. Dereń-Wesołek, A. Kłodzińska, P. Kowalski, S. Charakchieva-Minol, E. Tatarczyńska, T. Kowalska, Z. Majka, E. Chojnacka-Wójcik, S. Misztal, Pharmazie, in press.
2. R. Perrone, F. Berardi, M. Leopoldo, V. Tortorella, Il Farmaco 1995, 50, 505-510.
3. A. Orjales, L. Alonso-Cires, L. Labeaga, R. Corcostegui, J. Med. Chem. 1995, 38, 1273-1277.
4. W. Kuipers, I. van Wijngaarden, C. G. Kruse, M. ter Horst-van Amstel, M. Th. M. Tulp, A. P. IJzerman, J. Med. Chem. 1995, 38, 1942-1954.
5. B. J. van Steen, I. van Wijngaarden, M. Th. M. Tulp, W. Soudijn, J. Med. Chem. 1995, 38, 4303-4308.
6. P. Gaillard, P.-A. Carrupt, B. Testa, P. Schambel, J. Med. Chem. 1996, 39, 126-134.
7. J. L. Mokrosz, M. H. Paluchowska, A. Kłodzińska, S. Charakchieva-Minol, E. Chojnacka-Wójcik, Arch. Pharm. (Weinheim) 1995, 328, 770-774.
8. J. L. Mokrosz, M. H. Paluchowska, E. Chojnacka-Wójcik, M. Filip, S. Charakchieva-Minol, A. Dereń-Wesołek, M. J. Mokrosz, J. Med. Chem. 1994, 37, 2754-2760.
9. M. H. Paluchowska, A. Dereń-Wesołek, S. Charakchieva-Minol, E. Chojnacka-Wójcik, J. L. Mokrosz, Med. Chem. Res. 1995, 5, 479-486.
10. E. Przegaliński, M. Filip, M. Bijak, K. Wêdzony, B. Budziszewska, K. Tokarski, M. Mackowiak, K. Fijał, Pol. J. Pharmacol. 1996, 48, 13-22.
11. J. Yamawaki, T. Ando, T. Hanafusa, Chem. Lett. 1981, 1143-1145.
12. J. L. Mokrosz, A. Dereń-Wesołek, E. Tatarczyńska, B. Duszyńska, A. J. Bojarski, M. J. Mokrosz, E. Chojnacka-Wójcik, J. Med. Chem. 1996, 39, 1125-1129.
13. M. D. Tricklebank, C. Forler, J. R. Fozard, Eur. J. Pharmacol. 1985, 106, 271-282.
14. H. M. G. Berendsen, C. L. E. Broekkamp, A. M. L. Van Delft, Eur. J. Pharmacol. 1990, 187, 97-103.
15. P. Cassutti, A. Carugo, R. A. McArthur, Pharmacol. Res. 1995, 31 Suppl. 269.
16. A. J. Bojarski, M. T. Cegła, S. Charakchieva-Minol, M. J. Mokrosz, M. Mackowiak, S. Misztal, J. L. Mokrosz, Pharmazie 1993, 48, 289-295.
17. J. Maj, V. Klimek, G. Nowak, Eur. J. Pharmacol. 1985, 119, 113-116.
18. Y.-C. Cheng, W. H. Prusoff, Biochem. Pharmacol. 1973, 22, 3099.